ASSEMBLY BIOSCIENCES, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Assembly Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Assembly Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.73M, a 6.65% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.73M +$108K +6.65% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.04M -$383K -15.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.34M -$856K -26.8% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $844K -$3.11M -78.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.62M -$3.09M -65.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.42M -$2.88M -54.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.2M -$2.85M -47.1% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.96M -$2.82M -41.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.71M -$2.78M -37.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $5.3M -$2.8M -34.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $6.04M -$3.09M -33.8% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $6.77M -$3.62M -34.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $7.49M -$3.29M -30.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $8.1M -$3.38M -29.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.13M -$2.84M -23.7% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $10.4M -$2.39M -18.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $10.8M -$1.89M -14.9% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $11.5M -$1.58M -12.1% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $12M +$12M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $12.8M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $12.7M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $13.1M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.